NATHANIEL CERVANTES: Open Payments
NPI 1003287301 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 12 payments from 8 companies in 2025. Trend: 2023 $579 · 2024 $473 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Lilly USA, LLC | 1 | $114 |
| ABBVIE INC. | 3 | $64 |
| Ardelyx, Inc. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: CAPLYTA, MOUNJARO, VRAYLAR, IBSRELA, INGREZZA, IQIRVO, AUSTEDO XR, VOQUEZNA.
Industry payments across NM — which companies pay providers there.
